ARUP Laboratories Announces Availability of Natera’s Non-Invasive Prenatal Test, Panorama™

SALT LAKE CITY & SAN CARLOS, Calif.--(BUSINESS WIRE)--ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory, and Natera, a leading innovator in reproductive and prenatal genetic testing, today announced that Natera’s non-invasive prenatal screening test, Panorama™, is available to ARUP clients nationwide. The test is available for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner’s syndrome).